Crescent Biopharma Inc (CBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 0 | 0 | 0 | 19 | 20,071 |
| Gross Profit | N/A | N/A | N/A | 19 | 20,071 |
| Operating Expenses | 61,389 | 51,505 | 33,932 | 31,932 | 32,856 |
| Operating Income | -61,389 | -51,505 | -33,932 | -31,914 | -12,785 |
| Other Income | 3,497 | 3,231 | 651 | 104 | 15 |
| Pre-tax Income | -57,892 | -48,274 | -33,281 | -31,810 | -12,770 |
| Net Income Continuous | -57,892 | -48,274 | -33,281 | -31,810 | -12,770 |
| Net Income | $-57,892 | $-48,274 | $-33,281 | $-31,810 | $-12,770 |
| EPS Basic Total Ops | -134.00 | -118.00 | -113.00 | -150.00 | -67.00 |
| EPS Basic Continuous Ops | -133.84 | -117.61 | -113.22 | -149.65 | -67.17 |
| EPS Diluted Total Ops | -134.00 | -118.00 | -113.00 | -150.00 | -67.00 |
| EPS Diluted Continuous Ops | -133.84 | -117.61 | -113.22 | -149.65 | -67.17 |
| EPS Diluted Before Non-Recurring Items | -134.00 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-61,110 | $-51,230 | $-33,669 | $-31,723 | $-12,593 |